Lack of toxicity and persistence in the mouse associated with administration of candidate DNA- and modified vaccinia virus Ankara (MVA)-based HIV vaccines for Kenya

An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognized by class I major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes.

Hideo Takahashi, Jonah Cohen, Anne Hosmalin et al. · Proceedings of the National Academy of Sciences · 1988 · 411 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Effective Induction of Simian Immunodeficiency Virus-Specific Cytotoxic T Lymphocytes in Macaques by Using a Multiepitope Gene and DNA Prime-Modified Vaccinia Virus Ankara Boost Vaccination Regimen

Tomáš Hanke, Rachel V. Samuel, Tom Blanchard et al. · Journal of Virology · 1999 · 306 citations · Full text

Life Sciences, Immunology, Infectious Diseases +15

Induction of AIDS Virus-Specific CTL Activity in Fresh, Unstimulated Peripheral Blood Lymphocytes from Rhesus Macaques Vaccinated with a DNA Prime/Modified Vaccinia Virus Ankara Boost Regimen

Todd M. Allen, Thorsten U. Vogel, Deborah H. Fuller et al. · The Journal of Immunology · 2000 · 251 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +15

Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime

Thomas Hanke · Vaccine · 1998 · 222 citations

Life Sciences, Immunology, Immunization +11

Design and construction of an experimental HIV-1 vaccine for a year-2000 clinical trial in Kenya.

Tomáš Hanke, A J McMichael · Nature Medicine · 2000 · 196 citations

Veterinary Medicine, Immunology, Infectious Diseases +11